Discontinuation of Pneumocystis jirovecii pneumonia prophylaxis with CD4 count <200 cells/µL and virologic suppression: a systematic review.
<h4>Background</h4>HIV viral load (VL) is currently not part of the criteria for Pneumocystis jirovecii pneumonia (PCP) prophylaxis discontinuation, but suppression of plasma viremia with antiretroviral therapy may allow for discontinuation of PCP prophylaxis even with CD4 count <200...
Saved in:
| Main Authors: | Cecilia T Costiniuk, Dean A Fergusson, Steve Doucette, Jonathan B Angel |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2011-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0028570&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nonadherence to primary prophylaxis against Pneumocystis jirovecii pneumonia.
by: James D Heffelfinger, et al.
Published: (2009-01-01) -
Comment on “Pneumocystis jirovecii Pneumonia in a HIV-Infected Patient with a CD4 Count Greater Than 400 Cells/μL and Atovaquone Prophylaxis”
by: Gilles Nevez, et al.
Published: (2023-01-01) -
Neumonía por Pneumocystis Jirovecii
by: Residencia de Clínica Médica Hospital Italiano de Buenos Aires
Published: (2025-03-01) -
Clinical characteristics of Pneumocystis jirovecii pneumonia in hemodialysis patients
by: Na Young Kim, et al.
Published: (2025-04-01) -
Low-dose trimethoprim-sulfamethoxazole for prophylaxis of Pneumocystis jirovecii pneumonia in HIV-uninfected patients: a systematic review and meta-analysis
by: Hui-Bin Huang, et al.
Published: (2025-07-01)